161 related articles for article (PubMed ID: 30321230)
1. Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression.
Leighton X; Bera A; Eidelman O; Bubendorf L; Zellweger T; Banerjee J; Gelmann EP; Pollard HB; Srivastava M
PLoS One; 2018; 13(10):e0205837. PubMed ID: 30321230
[TBL] [Abstract][Full Text] [Related]
2. Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer.
Zellweger T; Ninck C; Mirlacher M; Annefeld M; Glass AG; Gasser TC; Mihatsch MJ; Gelmann EP; Bubendorf L
Prostate; 2003 Apr; 55(1):20-9. PubMed ID: 12640657
[TBL] [Abstract][Full Text] [Related]
3. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
[TBL] [Abstract][Full Text] [Related]
4. Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.
Torosyan Y; Simakova O; Naga S; Mezhevaya K; Leighton X; Diaz J; Huang W; Pollard H; Srivastava M
Int J Cancer; 2009 Dec; 125(11):2528-39. PubMed ID: 19610065
[TBL] [Abstract][Full Text] [Related]
5. ANXA7 expression represents hormone-relevant tumor suppression in different cancers.
Srivastava M; Torosyan Y; Raffeld M; Eidelman O; Pollard HB; Bubendorf L
Int J Cancer; 2007 Dec; 121(12):2628-36. PubMed ID: 17708571
[TBL] [Abstract][Full Text] [Related]
6. Annexin A7 is correlated with better clinical outcomes of patients with breast cancer.
Huang Y; Wang H; Yang Y
J Cell Biochem; 2018 Sep; 119(9):7577-7584. PubMed ID: 29893423
[TBL] [Abstract][Full Text] [Related]
7. Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer.
Bubendorf L; Tapia C; Gasser TC; Casella R; Grunder B; Moch H; Mihatsch MJ; Sauter G
Hum Pathol; 1998 Sep; 29(9):949-54. PubMed ID: 9744310
[TBL] [Abstract][Full Text] [Related]
8. Potential role of annexin A7 in cancers.
Guo C; Liu S; Greenaway F; Sun MZ
Clin Chim Acta; 2013 Aug; 423():83-9. PubMed ID: 23639634
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of Bcl-2 in clinically localized prostate cancer.
Bubendorf L; Sauter G; Moch H; Jordan P; Blöchlinger A; Gasser TC; Mihatsch MJ
Am J Pathol; 1996 May; 148(5):1557-65. PubMed ID: 8623924
[TBL] [Abstract][Full Text] [Related]
10. Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.
Zellweger T; Günther S; Zlobec I; Savic S; Sauter G; Moch H; Mattarelli G; Eichenberger T; Curschellas E; Rüfenacht H; Bachmann A; Gasser TC; Mihatsch MJ; Bubendorf L
Int J Cancer; 2009 May; 124(9):2116-23. PubMed ID: 19117060
[TBL] [Abstract][Full Text] [Related]
11. Application of a new technique, spiral tissue microarrays constructed using needle biopsy specimens, to prostate cancer research.
Komiya A; Kato T; Hori T; Fukuoka J; Yasuda K; Fuse H
Int J Oncol; 2014 Jan; 44(1):195-202. PubMed ID: 24220327
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Factors of Prostate Cancer in Tunisian Men: Immunohistochemical Study.
Missaoui N; Abdelkarim SB; Mokni M; Hmissa S
Asian Pac J Cancer Prev; 2016; 17(5):2655. PubMed ID: 27268646
[TBL] [Abstract][Full Text] [Related]
13. Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x.
Pollack A; Cowen D; Troncoso P; Zagars GK; von Eschenbach AC; Meistrich ML; McDonnell T
Cancer; 2003 Apr; 97(7):1630-8. PubMed ID: 12655519
[TBL] [Abstract][Full Text] [Related]
14. Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance.
Josefsson A; Wikström P; Egevad L; Granfors T; Karlberg L; Stattin P; Bergh A
Scand J Urol Nephrol; 2012 Aug; 46(4):247-57. PubMed ID: 22452635
[TBL] [Abstract][Full Text] [Related]
15. ANXA7-GTPase as Tumor Suppressor: Mechanisms and Therapeutic Opportunities.
Leighton X; Eidelman O; Jozwik C; Pollard HB; Srivastava M
Methods Mol Biol; 2017; 1513():23-35. PubMed ID: 27807828
[TBL] [Abstract][Full Text] [Related]
16. Role of multi-hnRNP nuclear complex in regulation of tumor suppressor ANXA7 in prostate cancer cells.
Torosyan Y; Dobi A; Glasman M; Mezhevaya K; Naga S; Huang W; Paweletz C; Leighton X; Pollard HB; Srivastava M
Oncogene; 2010 Apr; 29(17):2457-66. PubMed ID: 20190808
[TBL] [Abstract][Full Text] [Related]
17. SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis.
Liu S; Li X; Lin Z; Su L; Yan S; Zhao B; Miao J
Cancer Lett; 2018 Mar; 416():11-23. PubMed ID: 29247827
[TBL] [Abstract][Full Text] [Related]
18. Diverse effects of ANXA7 and p53 on LNCaP prostate cancer cells are associated with regulation of SGK1 transcription and phosphorylation of the SGK1 target FOXO3A.
Srivastava M; Leighton X; Starr J; Eidelman O; Pollard HB
Biomed Res Int; 2014; 2014():193635. PubMed ID: 24864229
[TBL] [Abstract][Full Text] [Related]
19. [Expression of annexin A7 and its clinical significance in gastric carcinoma].
Yuan HF; Li Y; Tan BB; Zhao Q; Fan LQ; Ye WH
Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):346-50. PubMed ID: 27188606
[TBL] [Abstract][Full Text] [Related]
20. The significance of ANXA7 expression and its correlation with poor cellular differentiation and enhanced metastatic potential of gastric cancer.
Hsu PI; Huang MS; Chen HC; Hsu PN; Lai TC; Wang JL; Lo GH; Lai KH; Tseng CJ; Hsiao M
J Surg Oncol; 2008 Jun; 97(7):609-14. PubMed ID: 18449914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]